Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

It gives Genome British Columbia great pleasure to present BC’s first Clinical Trials and Preclinical
Infrastructure Asset Map. This document, which was developed by International BioPharma
Solutions Ltd., strives to encapsulate the existing infrastructure and clinical trial activity of the
last five years. The document will be used by the community to better understand BC’s strengths
and to identify new opportunities: to build upon past investments and successes and to create a
world- class clinical research enterprise for the province.
In order to implement this strategy, the UBC Medical School, BC Health Authorities, Life Sciences
BC, Michael Smith Foundation for Health Research and Genome British Columbia have collaborated
and formed the British Columbia Clinical Research Infrastructure Network (BCCRIN).
This network will focus on building infrastructure to support clinical research activities and
personnel within BC, to compete on the world stage and attract inward investment. BCCRIN will
also endeavour to harmonize critical clinical research activities such as ethics, research
agreements and quality systems resulting in streamlined processes and enhanced efficiencies across
centres. Finally, investments in human resources, through training and development programs,
will be implemented to improve the recruitment and retention of the sectors’ ‘best and brightest’.
It is our hope that this asset map provides the foundation for a realistic business plan. Through the
implementation of this plan it is our goal to move clinical research forward in BC - and foster an
environment of collaboration which will result in increased private and public investmentbenefitting
all British Columbians.
BCCRIN has just appointed, Heather Harris-Harper, who comes with a wealth of 20 years clinical
research experience in both industrial and academic settings.
We look forward to working with the BC clinical research community to build a world-class research
enterprise for BC.
Pierre Meulien
Chief Scientific Officer
500 – 555 West 8 th Avenue, Vancouver BC V5Z 1C6 t. 604.738.8072 f. 604.738.8597 w. www.genomebc.ca